From Bristol Myers Squibb expanding their cardiovascular partnership with Avidity Biosciences' antibody-oligonucleotide conjugate technology, to Nurix and Seagen collaborating on a targeted protein degradation conjugate, there is now a staggering amount of investment and collaboration in the novel […]

Cell therapy continues to transform the oncology field, and this year has also seen the translation of cell therapies’ curative potential into the autoimmune space. Providing your team with exclusive […]

The Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Actively engage with the likes of Merck, Pfizer, SNIPR Biome, Locus Biosciences, Phiogen, AMR Action Fund […]